Loading company…
London-based developer of DMT-based therapies for patients with severe depression.
Small Pharma Ltd, founded in 2015 and based in London, UK, develops DMT-based therapies for patients with severe depression, positioned as an alternative to traditional antidepressants. The company trades on TSXV and OTCQB under the symbols DMT and DMTTF. In August 2023, Cybin Inc. acquired the company from ACF Investors. Peter Rands is President and CEO. Stage: Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in